跳至主要内容
临床试验/IRCT20191211045701N1
IRCT20191211045701N1尚未招募2 期

Comparison of oral zinc supplement and placebo effect in improving the T cells regeneration in patients undergoing autologous hematopoietic stem cell transplantation-clinical trial study

Tarbiat Modares University0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • Age range 40 to 60 years
  • Patients with a history of multiple myeloma on complete response to treatment
  • Patients are candidates for autologous hematopoietic stem cell transplantation
  • Confirmation of the patient's heart, kidney, liver, lung, and digestive system health before hematopoietic stem cell transplantation by a specialist

排除标准

  • History of sensitivity to zinc oral supplement
  • Patients who have taken oral supplements for three months before transplantation.
  • Serum levels above 200 mg/dl

研究者

相似试验